Literature DB >> 7049955

E.O.R.T.C. Gnotobiotic Project Group: a prospective cooperative study of antimicrobial decontamination in granulocytopenic patients. Comparison of two different methods.

.   

Abstract

In a cooperative and prospectively randomized study, two different methods of antimicrobial decontamination of the digestive tract with oral, nonabsorbable antibiotics were compared in neutropenic patients. In the first treatment group, the antibiotics were selected on the basis of the outcome of sensitivity tests performed on the flora of the patients. The other treatment group was given a standard combination of neomycin, cephaloridin, polymyxin B or E and nystatin or amphotericin B. Complete data from a total of 35 patients were received at the Statistical Center, and a minimum of 1.5 oral washings and faecal samples per week arrived at the Central Bacteriological Laboratory. There was no substantial difference in the clinical parameters of the patients in both treatment groups. Both methods for decontamination were found to be effective. The incidence of acquired infections and the quality of decontamination were almost identical in both groups. As far as the average number of negative cultures per patient is concerned, the results for both treatment groups are well in line with data found in other studies using a combination of gentamicin, vancomycin and nystatin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049955     DOI: 10.1007/bf01640762

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  14 in total

1.  Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results.

Authors:  M Dietrich; W Gaus; J Vossen; D van der Waaij; F Wendt
Journal:  Infection       Date:  1977       Impact factor: 3.553

2.  Gastrointestinal "sterilization" in the treatment of patients with acute leukemia.

Authors:  H D Preisler; I M Goldstein; E S Henderson
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

3.  Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.

Authors:  A S Levine; S E Siegel; A D Schreiber; J Hauser; H Preisler; I M Goldstein; F Seidler; R Simon; S Perry; J E Bennett; E S Henderson
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

4.  Protected environment-prophylactic antibiotic program in the chemotherapy of acute leukemia.

Authors:  G P Bodey; E A Gehan; E J Freireich; E Frei
Journal:  Am J Med Sci       Date:  1971-09       Impact factor: 2.378

5.  Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group.

Authors:  S C Schimpff; H Gaya; J Klastersky; M H Tattersall; S H Zinner
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

6.  Protocol for a comparative study of two methods for decontamination of the digestive tract.

Authors:  M Dietrich; W Gaus; J M Vossen; F Wendt; D van der Waaij
Journal:  Infection       Date:  1978       Impact factor: 3.553

7.  Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.

Authors:  D T Sleijfer; N H Mulder; H G de Vries-Hospers; V Fidler; H O Nieweg; D van der Waaij; H K van Saene
Journal:  Eur J Cancer       Date:  1980-06       Impact factor: 9.162

8.  A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients.

Authors:  J W Yates; J F Holland
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

9.  Partial antibiotic decontamination.

Authors:  H F Guiot; R Furth
Journal:  Br Med J       Date:  1977-03-26

10.  Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukaemia patients. III: The quality of isolation and decontamination.

Authors:  J Dankert; W Gaus; H Gaya; D Krieger; G Linzenmeier; D van der Waaij
Journal:  Infection       Date:  1978       Impact factor: 3.553

View more
  5 in total

Review 1.  Does oral vancomycin use necessitate therapeutic drug monitoring?

Authors:  Nevio Cimolai
Journal:  Infection       Date:  2019-11-11       Impact factor: 3.553

2.  Binding to faeces and influence on human anaerobes of antimicrobial agents used for selective decontamination.

Authors:  M P Hazenberg; M Van de Boom; M Bakker; J P Van de Merwe
Journal:  Antonie Van Leeuwenhoek       Date:  1983-06       Impact factor: 2.271

Review 3.  Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

Authors:  Anat Gafter-Gvili; Abigail Fraser; Mical Paul; Liat Vidal; Theresa A Lawrie; Marianne D van de Wetering; Leontien C M Kremer; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

4.  Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis.

Authors:  E Kurrle; A W Dekker; W Gaus; E Haralambie; D Krieger; M Rozenberg-Arska; H G de Vries-Hospers; D van der Waaij; F Wendt
Journal:  Infection       Date:  1986 Sep-Oct       Impact factor: 3.553

5.  Selective decontamination and the anaerobic faecal flora.

Authors:  M P Hazenberg; A M Pennock-Schröder
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.